[HTML][HTML] Efficacy and safety of adjunctive corticosteroids therapy for severe community-acquired pneumonia in adults: an updated systematic review and meta-analysis

J Bi, J Yang, Y Wang, C Yao, J Mei, Y Liu, J Cao, Y Lu - PLoS One, 2016 - journals.plos.org
… We performed a meta-analysis to evaluate the efficacy and safety of adjunctive … to evaluate
the efficacy and safety of adjunctive corticosteroids in the management of adult hospitalized …

Efficacy and safety of corticosteroids for community-acquired pneumonia: a systematic review and meta-analysis

YD Wan, TW Sun, ZQ Liu, SG Zhang, LX Wang… - Chest, 2016 - Elsevier
… Community-acquired pneumonia (CAP) is a common and serious infectious disease and …
in the inflammatory response associated with pneumonia. In multicenter randomized clinical …

… the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia

TM File Jr, J Segreti, L Dunbar, R Player… - Antimicrobial Agents …, 1997 - Am Soc Microbiol
… improved and if an efficacious and safe oral agent with which to … study was to compare
the efficacy and safety of intravenous and/… of adult patients with community-acquired pneumonia. …

[HTML][HTML] Efficacy and safety of glucocorticoids in the treatment of severe community-acquired pneumonia: a meta-analysis

S Jiang, T Liu, Y Hu, R Li, X Di, X Jin, Y Wang, K Wang - Medicine, 2019 - journals.lww.com
… Based on the above discrepancy, this paper evaluated the efficacy and safety of systemic
adjunctive glucocorticoids therapy in adult patients with severe CAP by means of meta-analysis…

[HTML][HTML] Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia: a systematic review and meta-analysis

J Huang, J Guo, H Li, W Huang, T Zhang - Medicine, 2019 - journals.lww.com
… community-acquired pneumonia (CAP) remains disputed in clinical practice. We undertook
a systematic review and meta-analysis to assess the efficacy and safety of corticosteroids in …

Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy

, … -Acquired Pneumonia Recovery in the … - Clinical infectious …, 2006 - academic.oup.com
… Limited prospective data are available for elderly patients with community-acquired pneumonia
(CAP). This study aimed to determine the efficacy and safety of moxifloxacin versus that …

Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial

A Castro-Guardiola, AL Viejo-Rodríguez… - The American journal of …, 2001 - Elsevier
… the safety, efficacy, and cost of oral therapy for patients with community-acquired pneumonia
The objective of our study was to investigate the safety and efficacy of administering oral …

Efficacy and safety of intravenous-to-oral lefamulin, a pleuromutilin antibiotic, for the treatment of community-acquired bacterial pneumonia: the phase III lefamulin …

TM File Jr, L Goldberg, A Das… - Clinical infectious …, 2019 - academic.oup.com
… This study demonstrated that efficacy of lefamulin, the first pleuromutilin for IV and oral use
in humans, was noninferior to that of moxifloxacin in adults with CABP. Noninferiority was …

A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults

, … Community-Acquired Pneumonia Study … - Clinical infectious …, 2002 - academic.oup.com
… patients hospitalized with community-acquired pneumonia were randomized to receive therapy
… similar efficacy and safety in hospitalized patients with community-acquired pneumonia. …

Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults

GS Tansarli, E Mylonakis - Antimicrobial agents and …, 2018 - Am Soc Microbiol
… analysis of outpatients with mild to moderate pneumonia or pneumonia of the Fine I/II class
(… and in the subgroup analysis of patients with severe pneumonia (90.3% versus 86.1%) (278 …